Pierce, J. P., Choi, W. S., Gilpin, E. A., Farkas, A. J., & Berry, C. C. (1998). Tobacco industry promotion
of cigarettes and adolescent smoking. JAMA, 279(7), 511-515.
Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk: What the evidence says.
Current Psychiatry, 10(9), 49-57.
Pignone, M., Earnshaw, S., Tice, J. A., & Pletcher, M. J. (2006). Aspirin, statins, or both drugs for the
primary prevention of coronary heart disease events in men: A cost-utility analysis. Annals of Internal
Medicine, 144(5), 326-336.
Piper, M. E., McCarthy, D. E., & Baker, T. B. (2006). Assessing tobacco dependence: A guide to measure
evaluation and selection. Nicotine & Tobacco Research, 8(3), 339-351.
Piper, M. E., Smith, S. S., Schlam, T. R., Fiore, M. C., Jorenby, D. E., Fraser, D., et al. (2009). A
randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of
General Psychiatry, 66(11), 1253-1262.
Pizacani, B. A., Rohde, K., Bushore, C., Stark, M. J., Maher, J. E., Dilley, J. A., et al. (2009). Smoking-
related knowledge, attitudes and behaviors in the lesbian, gay and bisexual community: A population-
based study from the U.S. Pacific Northwest. Preventive Medicine, 48(6), 555-561.
Placzek, A. N., Zhang, T. A., & Dani, J. A. (2009). Age dependent nicotinic influences over dopamine
neuron synaptic plasticity. Biochemical Pharmacology, 78(7), 686-692.
Polcin, D. L. (2001). Sober living houses: Potential roles in substance abuse services and suggestions for
research. Substance Use & Misuse, 36(3), 301-311.
Polcin, D. L., & Henderson, D. M. (2008). A clean and sober place to live: Philosophy, structure, and
purported therapeutic factors in sober living houses. Journal of Psychoactive Drugs, 40(2), 153-159.
Polcin, D. L., Korcha, R. A., Bond, J., & Galloway, G. (2010). Sober living houses for alcohol and drug
dependence: 18-month outcomes. Journal of Substance Abuse Treatment, 38(4), 356-365.
Poldrugo, F. (1997). Integration of pharmacotherapies in the existing programs for the treatment of
alcoholics: An international perspective. Journal of Addictive Diseases, 16(4), 65-82.
Poling, J., Oliveto, A., Petry, N., Sofuoglu, M., Gonsai, K., Gonzalez, G., et al. (2006). Six-month trial of
bupropion with contingency management for cocaine dependence in a methadone-maintained
population. Archives of General Psychiatry, 63(2), 219-228.
Pollack, H. A., & D'Aunno, T. (2008). Dosage patterns in methadone treatment: Results from a national
survey, 1988-2005. Health Services Research, 43(6), 2143-2163.
Pollak, M., Paicheler, G., & Pierret, J. (1992). AIDS: A problem for sociological research. London:
SAGE Publications.
Pollini, R. A., McCall, L., Mehta, S. H., Vlahov, D., & Strathdee, S. A. (2006). Non-fatal overdose and
subsequent drug treatment among injection drug users. Drug & Alcohol Dependence, 83(2), 104-110.
Pollio, D. E., McClendon, J., & Reid, D. (2004). Certification and program regulations for inpatient
services to youth with addiction: A state-level analysis. Journal of Psychoactive Drugs, 36(4), 499-
509.
Polosa, R., & Benowitz, N. L. (2011). Treatment of nicotine addiction: Present therapeutic options and
pipeline developments. Trends in Pharmacological Sciences, 32(5), 281-289.
Polsky, D., Glick, H. A., Yang, J., Subramaniam, G. A., Poole, S. A., & Woody, G. E. (2010). Cost-
effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: Data from a
randomized trial. Addiction, 105(9), 1616-1624.